Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Management of Azadirachtin 2% Poisoning

Immediate Priorities

  • The American Heart Association recommends contacting a poison control center immediately for expert guidance, as azadirachtin poisoning is rare and requires specialized toxicological consultation 1
  • Supportive care takes absolute priority over identification of the specific toxin or antidotal therapy, according to the American Heart Association 1
  • Hemodynamic monitoring and support are essential to maintain cardiovascular stability as part of supportive care 1
  • Correction of critical vital sign and metabolic derangements should be addressed immediately to ensure patient stability 1

Decontamination

  • The American Academy of Clinical Toxicology recommends removing all contaminated clothing and thoroughly washing exposed skin with soap and water to prevent continued absorption 2
  • Healthcare providers must use appropriate personal protective equipment to prevent secondary contamination, as advised by the American Academy of Clinical Toxicology 3
  • The American Academy of Clinical Toxicology advises against inducing vomiting, as this may worsen the condition and delay definitive care 2
  • Activated charcoal should not be administered unless specifically advised by poison control, due to uncertain benefits, according to the American Academy of Clinical Toxicology 2

Neurological Management

  • The American Heart Association recommends administering benzodiazepines, such as diazepam or midazolam, for seizures or agitation if they occur 1, 4

Monitoring Requirements

  • The American Academy of Clinical Toxicology suggests observing patients for at least 48-72 hours, even in apparently stable patients, due to the risk of delayed effects 3

Critical Pitfalls to Avoid

  • The American Academy of Clinical Toxicology advises against delaying treatment while waiting for confirmation of azadirachtin poisoning, and instead recommends treating based on clinical presentation and history of exposure 2
  • The American Academy of Clinical Toxicology warns against using neuromuscular blockers without adequate sedation if intubation is required, as they can mask seizure activity without treating it 4